Wegovy 1.7 mg FlexTouch pen (Semaglutide)

Description

Introduction

The Wegovy 1.7 mg FlexTouch pen (Semaglutide) is a prescription injectable medication formulated for chronic weight management and metabolic health support. Supplied as a pre-filled multi-dose delivery device containing the active pharmaceutical ingredient semaglutide, this formulation is typically utilized during targeted dose-escalation regimens or as an established maintenance level under clinical guidance.

What Is It?

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist class medication. The 1.7 mg strength pen delivers a measured dose of semaglutide designed for subcutaneous administration. It is indicated as an adjunct to a reduced-calorie meal plan and increased physical activity for individuals managing chronic weight-related profiles.

How Does It Work?

Semaglutide functions as a GLP-1 receptor agonist by mimicking the naturally occurring incretin hormone that regulates appetite and caloric intake. It targets specific receptors in the brain that moderate hunger signals and satiety. Additionally, it slows gastric emptying, which prolongs the feeling of fullness after eating and assists individuals in maintaining lower daily energy consumption.

Common Uses

This medication is prescribed for chronic weight management in adults with obesity or in overweight individuals who present with at least one weight-related comorbid condition, such as hypertension, dyslipidemia, or type 2 diabetes. It is used alongside sustained lifestyle interventions, including structured dietary modifications and regular exercise programs.

Available Strengths

• Wegovy 1 mg FlexTouch pen (Semaglutide)
• Wegovy 1.7 mg FlexTouch pen (Semaglutide)
• Wegovy 2.4 mg FlexTouch pen (Semaglutide)

Key Features

• Contains the active ingredient semaglutide in a 1.7 mg strength presentation.
• Configured in a FlexTouch pre-filled pen mechanism designed for subcutaneous self-injection.
• Engineered for once-weekly administration schedules.
• Includes compatibility with disposable pen needles for administration.
• Clear, colorless liquid formulation intended for visual inspection prior to use.

Benefits

• Supports significant reductions in body weight when combined with lifestyle modifications.
• Promotes sustained satiety and assists with appetite regulation between meals.
• Provides a convenient once-weekly dosing routine rather than daily administration requirements.
• FlexTouch mechanism allows straightforward dial-and-inject delivery mechanics.

Possible Side Effects

• Gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort.
• Fatigue, headache, dizziness, or mild injection-site reactions.
• Reduced appetite or feeling bloated following meals.
• Potential risk of hypoglycemia when used concurrently with insulin secretagogues or insulin therapies.

Precautions

• Do not use if there is a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
• Contraindicated during pregnancy; discontinue use if pregnancy is detected or planned.
• Not recommended for use in pediatric patients below 12 years of age or for indications outside chronic weight management.
• Avoid sharing pen devices or needles with other individuals to prevent cross-contamination.

Additional Precautions

• Inspect the solution visually prior to every injection; do not use if particles are visible or the liquid is discolored.
• Rotate subcutaneous injection sites between the abdomen, thigh, or upper arm to minimize local tissue irritation.
• Ask a healthcare professional for product-specific guidance regarding missed doses or schedule adjustments.
• Monitor renal function carefully if experiencing severe gastrointestinal fluid loss to prevent acute kidney injury.

Storage Instructions

• Store unopened pens in a refrigerator between 2°C and 8°C. Do not freeze the pen, and discard if freezing has occurred.
• Once in use, the pen may be kept at room temperature below 30°C for up to 28 days.
• Keep the pen cap attached when not in use to protect the contents from light exposure.
• Keep out of the reach of children and domestic animals.

How to Take

• Administer subcutaneously once weekly on the same day each week, at any time of day, with or without food.
• Select an injection site on the abdomen, thigh, or upper arm, cleaning the area prior to application.
• Attach a new sterile needle for each individual injection and check the flow if utilizing a new pen.
• Press the pen firmly against the skin and hold until the dose counter returns to zero.

Drug Interactions

• Concomitant administration with oral medications that have a narrow therapeutic index requires careful monitoring due to delayed gastric emptying.
• Co-administration with insulin or sulfonylureas may increase the likelihood of low blood sugar events.
• Inform prescribing clinicians of all prescription drugs, over-the-counter remedies, and herbal supplements currently taken.

Why Choose This Product?

• Features the verified active compound semaglutide formulated for targeted clinical dosing.
• Delivers precise volume management via the FlexTouch pre-filled pen format.
• Integrates cleanly into established weekly chronic weight management protocols.

Frequently Asked Questions (FAQs)

What should I do if I miss a weekly dose of Wegovy?

If a dose is missed, take it as soon as possible within 5 days after the missed date. If more than 5 days have passed, skip the missed dose and resume the normal once-weekly schedule. Ask a healthcare professional for product-specific guidance if multiple doses are missed.

Can the Wegovy 1.7 mg pen be injected into any part of the body?

Injections should be administered subcutaneously into the abdomen, thigh, or upper arm. Rotate the specific injection site each week, ensuring you do not use the exact same spot for consecutive injections.

Does Wegovy need to be stored in the refrigerator permanently?

Unopened pens must be refrigerated between 2°C and 8°C. Once the pen has been brought into active use, it can be stored at room temperature below 30°C for up to 28 days.

Is it necessary to use a new needle for every injection?

Yes, a fresh, sterile disposable needle must be attached for every single injection to maintain hygiene, prevent contamination, and ensure accurate delivery.

What is the primary role of semaglutide in this formulation?

Semaglutide acts as a GLP-1 receptor agonist that mimics natural incretin hormones to help suppress appetite, enhance feelings of fullness, and assist with calorie reduction.

Can I consume food normally while using this medication?

Wegovy should be used alongside a reduced-calorie diet and increased physical activity. Because the medication slows digestion and reduces appetite, smaller, nutrient-dense meals are typically recommended.

What should I look for during visual inspection of the pen?

Check the viewing window on the pen to confirm that the liquid solution is clear, colorless, and free of particles before proceeding with the injection.

Who should avoid using the Wegovy 1.7 mg pen?

Individuals with a personal or family history of medullary thyroid carcinoma, those with known hypersensitivity to semaglutide, and pregnant or breastfeeding individuals should not use this product.